Glico has received official “letter of no objection” from the Food and Drug Administration (FDA) regarding the self-affirmed Generally Recognized as Safe (GRAS) status of its Cyclic Dextrin, Highly Branched, marketed as Cluster Dextrin® or CCD®, produced via a patented enzymatic method.(Applicant: Ezaki Glico Co., Ltd.; GRAS Notice No.: GRN 000404).
CCD has been on the market in Japan since 2002 as a food material, and is used for improvement of taste or physical properties of food. CCD has also been used as component of sports drink, as a spray-drying aid and so on. After obtaining a self-affirmed GRAS status, CCD has been on the U.S. market since 2008, mainly as an ingredient for sports supplement.
Glico considers that the FDA’s confirmation paves the way for CCD to be used in a wide range of food and beverages, including sports beverages, juices, teas, specialty bottled waters, bars, confectionaries and candies.
Cluster Dextrin is a high-molecular-weight (around 400,000) maltodextrin constructed from approximately 2,500 glucose units. Its molecular weight distribution is much narrower than conventional maltodextrin. Because of the properties CCD has the following properties:
- CCD is highly soluble in water, and the solution is highly soluble during storage.
- CCD is completely degraded to glucose by rat intestine homogenate (including digestive enzymes) at a comparable rate to conventional maltodextrins.
- CCD has low unfavorable taste.
- CCD absorbs very little moisture. Furthermore, CCD hardly causes a browning reaction. These properties make CCD excellent as a beverage base and a spray-drying aid.